Ideaya Biosciences Inc. Revenue 2019–2025
Ideaya Biosciences Inc. annual/quarterly revenue history and growth rate from 2019 to 2026. Revenue can be defined as the amount of money a company receives from its customers in exchange for the sale of goods or services. Revenue is the top line item on an income statement from which all costs and expenses are subtracted to arrive at net income.
- Ideaya Biosciences Inc. revenue for the quarter ending March 31, 2026 was 6.6 M.
- Ideaya Biosciences Inc. revenue for the twelve months ending March 31, 2026 was 214.4 M, a 1001.60% increase year-over-year.
- Ideaya Biosciences Inc. annual revenue for 2025 was 218.7 M, a 3024.43% increase from 2024.
- Ideaya Biosciences Inc. annual revenue for 2024 was 7.0 M, a 70.07% decrease from 2023.
- Ideaya Biosciences Inc. annual revenue for 2023 was 23.4 M, a 54.08% decrease from 2022.
- Ideaya Biosciences Inc. annual revenue for 2022 was 50.9 M.
Ideaya Biosciences Inc. (IDYA) — Frequently Asked Questions
Ideaya Biosciences Inc. (IDYA) is a publicly traded US company. It has a market capitalization of $2.57B. In fiscal 2025 it reported revenue of $219M and net income of -$114M. Explore IDYA's stock price, financial statements, earnings history, margins and key ratios below.
What is Ideaya Biosciences Inc.'s market cap?
Ideaya Biosciences Inc. (IDYA) has a market capitalization of $2.57B.
What is the IDYA stock price?
IDYA trades at $29.04 (+5.20% on the day).
How much revenue does Ideaya Biosciences Inc. make?
Ideaya Biosciences Inc. reported revenue of $219M in fiscal 2025.
Is IDYA profitable?
In fiscal 2025, Ideaya Biosciences Inc. reported net income of -$114M.